Compass Pathways Plc (CMPS) - Total Assets
Based on the latest financial reports, Compass Pathways Plc (CMPS) holds total assets worth $210.35 Million USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Compass Pathways Plc balance sheet quality to measure how much of total assets are equity-financed.
Compass Pathways Plc - Total Assets Trend (2018–2025)
This chart illustrates how Compass Pathways Plc's total assets have evolved over time, based on quarterly financial data. Explore investment intensity of Compass Pathways Plc to see how much of total assets are deployed in long-term investments.
Compass Pathways Plc - Asset Composition Analysis
Current Asset Composition (December 2025)
Compass Pathways Plc's total assets of $210.35 Million consist of 91.0% current assets and 9.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 71.1% |
| Accounts Receivable | $15.39 Million | 7.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2018–2025)
This chart illustrates how Compass Pathways Plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Compass Pathways Plc stock valuation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Compass Pathways Plc's current assets represent 91.0% of total assets in 2025, a decrease from 99.6% in 2018.
- Cash Position: Cash and equivalents constituted 71.1% of total assets in 2025, down from 86.8% in 2018.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2018.
- Asset Diversification: The largest asset category is accounts receivable at 7.3% of total assets.
Compass Pathways Plc Competitors by Total Assets
Key competitors of Compass Pathways Plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Extendicare Inc
TO:EXE
|
Canada | CA$1.07 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
Sienna Senior Living Inc
TO:SIA
|
Canada | CA$2.35 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
|
Community Health Systems Inc
NYSE:CYH
|
USA | $13.18 Billion |
|
Hospital Mater Dei S.A
SA:MATD3
|
Brazil | R$4.40 Billion |
|
Lokman Hekim Engurusag Saglik Turizm Egitim Hizmetleri ve Insaat Taahhut AS
IS:LKMNH
|
Turkey | TL5.27 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
Compass Pathways Plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.77 | 5.92 | 25.53 |
| Quick Ratio | 0.77 | 5.92 | 24.68 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-56.30 Million | $167.28 Million | $187.41 Million |
Compass Pathways Plc - Advanced Valuation Insights
This section examines the relationship between Compass Pathways Plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 16.11 |
| Latest Market Cap to Assets Ratio | 6.36 |
| Asset Growth Rate (YoY) | -1.6% |
| Total Assets | $210.35 Million |
| Market Capitalization | $1.34 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Compass Pathways Plc's assets at a significant premium (6.36x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Compass Pathways Plc's assets decreased by 1.6% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Compass Pathways Plc (2018–2025)
The table below shows the annual total assets of Compass Pathways Plc from 2018 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $210.35 Million | -1.55% |
| 2024-12-31 | $213.67 Million | -22.58% |
| 2023-12-31 | $275.99 Million | +39.89% |
| 2022-12-31 | $197.29 Million | -34.43% |
| 2021-12-31 | $300.90 Million | +47.89% |
| 2020-12-31 | $203.46 Million | +528.16% |
| 2019-12-31 | $32.39 Million | +22.75% |
| 2018-12-31 | $26.39 Million | -- |
About Compass Pathways Plc
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly … Read more